StockStory.org on MSN
Illumina (NASDAQ:ILMN) surprises with Q2 CY2026 sales, full-year outlook slightly exceeds expectations
Genomics company Illumina (NASDAQ:ILMN) reported in Q2 CY2026, with sales up 9.4% year on year to $1.16 billion. The ...
Transcriptomics is the study of the transcriptome—the complete set of RNA transcripts that are produced by the genome, under specific circumstances or in a specific cell—using high-throughput methods, ...
The GeneTitan® family of instruments and proven GeneChip® Array Plates from Thermo Fisher Scientific are the first to provide a hands-free, automated solution for monitoring gene expression and genome ...
Analysis of variances (ANOVA) is a statistical examination of the differences between all of the variables used in an ...
Official GMAT or GRE test results, taken within five years from the term of entrance, are required. Other exemptions and waivers may be available. Learn more by clicking Application Process. If ...
Cancer imaging is moving from a purely diagnostic tool to a source of measurable, reproducible data that can guide treatment decisions and trial outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results